2021
DOI: 10.21203/rs.3.rs-1032864/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Evaluation of Early Innate and Adaptive Immune Responses to the TB Vaccine Mycobacterium Bovis BCG and Vaccine Candidate BCGdBCG1419c

Abstract: The vaccine Mycobacterium bovis Bacillus Calmette–Guérin (BCG) elicits an immune response that is protective against certain forms of tuberculosis (TB); however, because BCG efficacy is limited it is important to identify alternative TB vaccine candidates. Recently, the BCG deletion mutant and vaccine candidate BCGDBCG1419c was demonstrated to survive longer in intravenously infected BALB/c mice due to enhanced biofilm formation, and better protected both BALB/c and C57BL/6 mice against TB-induced lung patholo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…SCXK Jing 2021-0006) and randomly divided into ve groups of 15 mice each (Table 2). Immunization was performed by subcutaneous injection at 2-week intervals, and the BCG dose was based on relevant studies [21]. Samples were collected at 0, 14, 28, 35 and 42 days after immunization (DAI), and three mice in each group were cervically dislocated and sacri ced at 35 and 42 DAI.…”
Section: Mouse Vaccinationmentioning
confidence: 99%
“…SCXK Jing 2021-0006) and randomly divided into ve groups of 15 mice each (Table 2). Immunization was performed by subcutaneous injection at 2-week intervals, and the BCG dose was based on relevant studies [21]. Samples were collected at 0, 14, 28, 35 and 42 days after immunization (DAI), and three mice in each group were cervically dislocated and sacri ced at 35 and 42 DAI.…”
Section: Mouse Vaccinationmentioning
confidence: 99%